Latest news
The FDA Gives Accelerated Approval to Melanoma Treatment - pharmtech.compharmtech.com · Fri, 07 Aug 2026 14:55:43 GMTEmavusertib-Based Therapy Produces Responses in BTK Inhibitor–Treated Primary CNS Lymphoma - Pharmacy TimesPharmacy Times · Mon, 27 Jul 2026 19:52:26 GMTCRISPR makes prostate cancer vulnerable to immunotherapy - ScienceDailyScienceDaily · Sun, 26 Jul 2026 07:00:00 GMT